Feline Injection Site Sarcomas: Data from Switzerland 2009-2014

Journal of Comparative Pathology
R GrafA Pospischil

Abstract

Feline injection site sarcomas (FISS) were first described in the early 1990s. Despite extensive research, the pathogenesis of these tumours has not been elucidated conclusively. Their appearance and the marked increase in their incidence has been mainly connected to the injection of vaccines, and it is assumed that a chronic inflammatory reaction at the injection site triggers subsequent malignant transformation. The role of alum-based adjuvants has been discussed, but is controversial. The present study of the Swiss Feline Cancer Registry (SFCR) with data from 2009 to 2014 revealed a marked decrease of the incidence of fibrosarcomas compared with the previous observation period. Notably, this drop occurred after a non-adjuvanted feline leukaemia virus vaccine was introduced in Switzerland in 2007. This observation, together with the previous findings of the SFCR, further supports the notion that alum-adjuvanted vaccines are involved in the genesis of FISS and that non-adjuvanted vaccines might be safer for cats.

Citations

Aug 28, 2020·Journal of Feline Medicine and Surgery·Amy Es StoneMark E Westman
Aug 7, 2021·Laboratory Animals·Christopher Cheleuitte-NievesSébastien Monette

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Related Papers

The Veterinary Record
Rachel S DeanKen Smith
The Journal of Small Animal Practice
Journal of the American Veterinary Medical Association
M J Hendrick, M H Goldschmidt
Seminars in Veterinary Medicine and Surgery (small Animal)
D W Macy
© 2022 Meta ULC. All rights reserved